Meanwhile, data began accumulating on the pathophysiological changes in leptin production and signaling that take place in obese subjects (13), eventually leading to realization of the unfeasibility and lack of strong biological basis for using leptin as a therapeutic approach to obesity. This evidence concerns the gene LEP and obesity disorder.